MMP26 | Matrix metallopeptidase 26 | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MMP10 | Matrix metallopeptidase 10 (stromelysin 2) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
TEX15 | Testis expressed 15 | Predicted intracellular proteins
| | | | | Group enriched |
PRLHR | Prolactin releasing hormone receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
PAEP | Progestagen-associated endometrial protein | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
CHRDL2 | Chordin-like 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PRL | Prolactin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
RP4-559A3.7 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000414068} | Predicted intracellular proteins
| | | | | Tissue enriched |
FRMD7 | FERM domain containing 7 | Cancer-related genes Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
DCX | Doublecortin | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
FOXL2 | Forkhead box L2 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
SCGB1D2 | Secretoglobin, family 1D, member 2 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
SLC6A2 | Solute carrier family 6 (neurotransmitter transporter), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ZCCHC12 | Zinc finger, CCHC domain containing 12 | Predicted intracellular proteins
| | | | | Group enriched |
NXNL2 | Nucleoredoxin-like 2 | Predicted intracellular proteins
| | | | | Group enriched |
SERTM1 | Serine-rich and transmembrane domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
SLC46A2 | Solute carrier family 46, member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
DLX5 | Distal-less homeobox 5 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
ESYT3 | Extended synaptotagmin-like protein 3 | Predicted membrane proteins
| | | | | Group enriched |
MMP3 | Matrix metallopeptidase 3 (stromelysin 1, progelatinase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | Predicted intracellular proteins
| | | | | Group enriched |
TMEM215 | Transmembrane protein 215 | Predicted membrane proteins
| | | | | Group enriched |
AGTR2 | Angiotensin II receptor, type 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
ANO4 | Anoctamin 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ASIC2 | Acid-sensing (proton-gated) ion channel 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CDC20B | Cell division cycle 20B | Predicted intracellular proteins
| | | | | Group enriched |
EMX2 | Empty spiracles homeobox 2 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
FOXL2NB | FOXL2 neighbor | Predicted intracellular proteins
| | | | | Group enriched |
IHH | Indian hedgehog | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
TMEM196 | Transmembrane protein 196 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
TRH | Thyrotropin-releasing hormone | Predicted secreted proteins
| | | | | Tissue enriched |
WNT2 | Wingless-type MMTV integration site family member 2 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
CAPN6 | Calpain 6 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Group enriched |
DLX6 | Distal-less homeobox 6 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
GABRQ | Gamma-aminobutyric acid (GABA) A receptor, theta | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
HOXA11 | Homeobox A11 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
KIAA1644 | KIAA1644 | Predicted membrane proteins
| | | | | Group enriched |
AC006486.9 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000470087} | Predicted intracellular proteins
| | | | | Tissue enhanced |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ALDH1A2 | Aldehyde dehydrogenase 1 family, member A2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AP000349.2 | PP13850 {ECO:0000313|EMBL:AAQ15253.1} | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf64 | Chromosome 1 open reading frame 64 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1QTNF6 | C1q and tumor necrosis factor related protein 6 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C8orf31 | Chromosome 8 open reading frame 31 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CACNA1G | Calcium channel, voltage-dependent, T type, alpha 1G subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |